⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
GOSS
Form 8-K
sec.gov
GOSS
Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support
businesswire.com
GOSS
GOSS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
GOSS
Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update
businesswire.com
GOSS
Class Action Lawsuit Reminder from Pomerantz LLP for Investors of Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Pomerantz LLP Updates Investors on Legal Action Brought Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 Ready to Announce with Confidence?
newsfilecorp.com
GOSS
GOSS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
GOSS
Pomerantz LLP Updates Shareholders on Legal Action Brought Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS